Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for …
EE Ozkan - Molecular and cellular endocrinology, 2011 - Elsevier
Cancer database analysis indicates that prostate cancer is one of the most seen cancers in
men meanwhile composing the leading cause of morbidity and mortality among developed …
men meanwhile composing the leading cause of morbidity and mortality among developed …
Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for …
EE Ozkan - Molecular and Cellular Endocrinology, 2011 - hero.epa.gov
Cancer database analysis indicates that prostate cancer is one of the most seen cancers in
men meanwhile composing the leading cause of morbidity and mortality among developed …
men meanwhile composing the leading cause of morbidity and mortality among developed …
Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for …
EE Ozkan - Molecular and cellular endocrinology, 2011 - pubmed.ncbi.nlm.nih.gov
Cancer database analysis indicates that prostate cancer is one of the most seen cancers in
men meanwhile composing the leading cause of morbidity and mortality among developed …
men meanwhile composing the leading cause of morbidity and mortality among developed …
Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for …
EE Ozkan - Molecular and Cellular Endocrinology, 2011 - europepmc.org
Cancer database analysis indicates that prostate cancer is one of the most seen cancers in
men meanwhile composing the leading cause of morbidity and mortality among developed …
men meanwhile composing the leading cause of morbidity and mortality among developed …
Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for …
EE Ozkan - Molecular and Cellular Endocrinology, 2011 - infona.pl
Cancer database analysis indicates that prostate cancer is one of the most seen cancers in
men meanwhile composing the leading cause of morbidity and mortality among developed …
men meanwhile composing the leading cause of morbidity and mortality among developed …
[引用][C] Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy …
EE Ozkan - Molecular and Cellular Endocrinology, 2011 - cir.nii.ac.jp
Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for
prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A …
prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A …